Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil



FUSION PROTEIN COMPRISING THE EXTRACELLULAR DOMAIN OF A FILOVIRUS GLYCOPROTEIN FUSED TO AN IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION

This invention provides fusion proteins comprising a Filovirus glycoprotein segment and an immunoglobulin polypeptide segment. The fusion proteins are useful in immunogenic compositions to protect against infections by Filoviruses, such as Ebola virus, in both humans and non-human animals. The fusion proteins are also useful in diagnostic assays to detect Filovirus infections.


Docket:RIID 12-08

Publication/Issued No.:9,347,951

Publication/Issue Date:2016-05-24

Categories: Assay

More Detail:Visit USPTO.GOVExternal link

Lab:RIID

Inventor(s):KAPLAN, ET AL


For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil
 

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at:
USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil or by telephone at (301)619-2736.